We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,062 results
  1. Advances in myelodysplastic/myeloproliferative neoplasms

    The myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN) category includes a heterogeneous group of diseases characterized by the...

    Sonam Prakash, Daniel A. Arber, ... Attilio Orazi in Virchows Archiv
    Article 05 December 2022
  2. Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)

    8p11 myeloproliferative syndrome is a rare hematological malignancy caused by the translocation of FGFR1. Patients present with a myeloproliferative...

    Fumi Nakamura, Sachiko Seo, ... Kinuko Mitani in International Journal of Hematology
    Article Open access 17 March 2023
  3. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms

    Predicting the likelihood vascular events in patients with BCR/ABL1-negative myeloproliferative neoplasms (MPN) is essential for the treatment of the...

    Kangle Huang, Qiuyu Mo, ... ** Lei in Clinical and Experimental Medicine
    Article Open access 22 May 2024
  4. Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives

    In this Perspective , we discuss criteria for defining a new disease entity or variant of a recognized disease or disorder. We do so in the context of...

    Giovanni Barosi, Vittorio Rosti, Robert Peter Gale in Leukemia
    Article Open access 04 March 2023
  5. A review of current knowledge of myeloproliferative disorders in the horse

    Myeloid disorders are conditions being characterized by abnormal proliferation and development of myeloid lineage including granulocytes...

    Katy Satué, Juan Carlos Gardon, Ana Muñoz in Acta Veterinaria Scandinavica
    Article Open access 23 February 2021
  6. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group

    Myeloproliferative neoplasms (MPN) are a heterogeneous group of clonal hematopoietic stem cell disorders characterized clinically by the...

    Harinder Gill, Garret M. K. Leung, ... Yok-Lam Kwong in Clinical and Experimental Medicine
    Article 25 September 2023
  7. International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms

    The recently published International Consensus Classification (ICC) of myeloid neoplasms summarized the results of an in-depth effort by...

    Umberto Gianelli, Jürgen Thiele, ... Hans Michael Kvasnicka in Virchows Archiv
    Article Open access 29 December 2022
  8. Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms

    Typical BCR::ABL1-negative myeloproliferative neoplasms (MPN) are mainly referred to as polycythemia vera (PV), essential thrombocythemia (ET), and...

    Fengting Liang, Xuelan Liang, ... **uhua Chen in Clinical and Experimental Medicine
    Article Open access 21 May 2024
  9. Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing

    The role of next-generation sequencing (NGS) in identifying mutations in the driver, epigenetic regulator, RNA splicing, and signaling pathway genes...

    Madhavi Maddali, Arvind Venkatraman, ... Poonkuzhali Balasubramanian in Annals of Hematology
    Article 15 July 2022
  10. Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report

    Background

    Bilateral adrenal infarction is rare and only a small number of cases have been reported so far. Adrenal infarction is usually caused by...

    Yoshitomo Hoshino, Katsunori Manaka, ... Noriko Makita in BMC Endocrine Disorders
    Article Open access 05 June 2023
  11. Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency

    Myeloproliferative neoplasms (MPN) are chronic clonal disorders characterized by overproduction of myeloid-lineage blood cells and potential risk of...

    Michael J. Hochman, B. Douglas Smith, ... Amy E. DeZern in International Journal of Hematology
    Article 01 October 2022
  12. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer

    Purpose of Review

    This review focuses on vascular complications associated with chronic myeloproliferative neoplasms (MPN) and more specifically aims...

    Tiziano Barbui, Antonello Gavazzi, ... Alessandra Carobbio in Current Hematologic Malignancy Reports
    Article 24 May 2023
  13. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

    Myeloproliferative neoplasms (MPN) are a heterogeneous group of hematological disorders presenting with an increased proliferation in one or several...

    Fermin Person, Sara C. Meyer, ... Thomas Menter in Virchows Archiv
    Article Open access 23 June 2021
  14. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms

    Myeloproliferative neoplasms (MPN) are hematological disorders characterized by increased proliferation of precursor and mature myeloid cells. MPN...

    Maira da Costa Cacemiro, Juçara Gastaldi Cominal, ... Fabíola Attié de Castro in Medical Oncology
    Article 23 May 2022
  15. Dermatologic manifestations of hematologic disorders

    Distinguishing key morphologic features and understanding the pathophysiology of common cutaneous manifestations of hematologic disorders is...

    Hannah L. King, Genevieve B. Benedetti, ... Kylee L. Martens in Annals of Hematology
    Article 25 April 2024
  16. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives

    The exact prognostic role of cardiovascular (CV) risk factors in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms (MPNs) remains...

    Ivan Krecak, Srdan Verstovsek, Marko Lucijanic in Annals of Hematology
    Article 04 September 2023
  17. Atypical Megakaryocyte Morphology: an Important Diagnostic Clue for JAK2 Mutation–Associated Disorders

    Chronic myeloproliferative neoplasm (MPN) is a diverse group of bone marrow disorders. These include BCR-ABL fusion gene–related disorders or...

    Mohit Rajpal, Sankalp Sancheti, ... Akash Pramod Sali in SN Comprehensive Clinical Medicine
    Article 16 November 2022
  18. The role of flow cytometry in the classification of myeloid disorders

    The World Health Organization classification (WHO-HAEM5) and the International Consensus Classification (ICC 2022) of myeloid neoplasms are based on...

    Leonie Saft in Die Pathologie
    Article Open access 22 November 2023
  19. ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

    Hassan Awada, Manasa Bhatta, ... Amro Elshoury in Leukemia
    Article 03 November 2023
Did you find what you were looking for? Share feedback.